A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/522 (2006.01) A61K 31/52 (2006.01) A61P 31/12 (2006.01) A61P 31/22 (2006.01) C07D 473/18 (2006.01)
Patent
CA 2207503
A method for the treatment of latent infection of herpes viruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A) or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.
Procédé de traitement de l'infection latente par les herpèsvirus chez les mammifères, notamment chez l'homme, consistant à administrer au mammifère nécessitant un tel traitement, une dose efficace d'un composé de la formule (A), ou d'un bioprécurseur de celui-ci, ou d'un sel, d'un ester de phosphate et/ou d'un dérivé acyle de l'un ou l'autre, acceptables sur le plan pharmacologique.
Bacon Teresa Helen
Field Hugh John
Sutton David
Thackray Alana Maureen
Vere Hodge Richard Anthony
Gowling Lafleur Henderson Llp
Novartis International Pharmaceutical Ltd.
Smithkline Beecham P.l.c.
LandOfFree
Use of aminopurine antiviral agents for the treatment and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of aminopurine antiviral agents for the treatment and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of aminopurine antiviral agents for the treatment and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1916064